These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
677 related articles for article (PubMed ID: 26670548)
1. Central kynurenine pathway shift with age in women. de Bie J; Guest J; Guillemin GJ; Grant R J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548 [TBL] [Abstract][Full Text] [Related]
2. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279 [TBL] [Abstract][Full Text] [Related]
3. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788 [TBL] [Abstract][Full Text] [Related]
4. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats. Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336 [TBL] [Abstract][Full Text] [Related]
6. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations. Tan L; Yu JT; Tan L J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820 [TBL] [Abstract][Full Text] [Related]
7. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142 [TBL] [Abstract][Full Text] [Related]
8. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder. Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831 [TBL] [Abstract][Full Text] [Related]
9. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain. Fuertig R; Ceci A; Camus SM; Bezard E; Luippold AH; Hengerer B Bioanalysis; 2016 Sep; 8(18):1903-17. PubMed ID: 27524289 [TBL] [Abstract][Full Text] [Related]
10. Metabolism of [5-(3)H]kynurenine in the developing rat brain in vivo: effect of intrastriatal ibotenate injections. Ceresoli G; Guidetti P; Schwarcz R Brain Res Dev Brain Res; 1997 May; 100(1):73-81. PubMed ID: 9174248 [TBL] [Abstract][Full Text] [Related]
11. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655 [TBL] [Abstract][Full Text] [Related]
12. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Saito K; Markey SP; Heyes MP Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184 [TBL] [Abstract][Full Text] [Related]
13. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy. Ryan KM; Allers KA; McLoughlin DM; Harkin A Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477 [TBL] [Abstract][Full Text] [Related]
14. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease. Badawy AA Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600 [TBL] [Abstract][Full Text] [Related]
15. CSF neopterin, quinolinic acid and kynurenine/tryptophan ratio are biomarkers of active neuroinflammation. Yan J; Kothur K; Mohammad S; Chung J; Patel S; Jones HF; Keating BA; Han VX; Webster R; Ardern-Holmes S; Antony J; Menezes MP; Tantsis E; Gill D; Gupta S; Kandula T; Sampaio H; Farrar MA; Troedson C; Andrews PI; Pillai SC; Heng B; Guillemin GJ; Guller A; Bandodkar S; Dale RC EBioMedicine; 2023 May; 91():104589. PubMed ID: 37119734 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. Saito K; Nowak TS; Markey SP; Heyes MP J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138 [TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis. Rajda C; Galla Z; Polyák H; Maróti Z; Babarczy K; Pukoli D; Vécsei L Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290514 [TBL] [Abstract][Full Text] [Related]
18. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923 [TBL] [Abstract][Full Text] [Related]
19. Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders. Savitz J Curr Top Behav Neurosci; 2017; 31():249-267. PubMed ID: 27221627 [TBL] [Abstract][Full Text] [Related]